Alteplase in preventing posterior capsule opacity by plasminogen activator inhibitor-1 and type I collagen expression inhibition in a posterior capsule opacity model with fibrin reaction in vitro: A experimental laboratory study

• Main Authors: Rina Wulandari, Indri Wahyuni, Arifa Mustika, Windhu Purnomo, Nurwasis
• Format: Article PeerReviewed
• Language: English; English; English
• Published: DR.P.R.YADAV 2019
• Subjects: R Medicine (General); RE Ophthalmology
• Online Access: http://repository.unair.ac.id/104157/1/Alteplase.pdf; http://repository.unair.ac.id/104157/2/Alteplase%20in%20preventing.pdf; http://repository.unair.ac.id/104157/3/Alteplase%20in%20preventing%20posterior%20capsule%20opacity%20by%20plasminogen%20activator%20inhibitor-1%20and%20type%20I%20collagen%20expression%20inhibition%20in%20a%20posterior%20capsule%20opacity%20model%20with%20fibrin%20reaction%20in%20vitro_%20A.pdf; http://repository.unair.ac.id/104157/; http://www.connectjournals.com/toc2.php?abstract=3066000H_4695A.pdf&&bookmark=CJ-033216&&issue_id=Supp-02&&yaer=2019
• Institution: Universitas Airlangga

To investigate the effect of alteplase on plasminogen activator inhibitor -1 (PAI-1) and type I collagen expression in a posterior capsule opacity (PCO) model with fibrin reaction in vitro. Cultured human lens epithelial cells (HLEC) were isolated from the anterior lens capsule following a capsuloto...